425: Gentherm Reports Q2 2026 Results, Merger on Track

Gentherm announced strong second quarter 2026 results, raising full-year guidance and confirming the merger with Modine Performance Technologies is on schedule for an early Q4 close.

Summary

• Gentherm reported a 9.5% year-over-year revenue growth (excluding foreign currency) to $416 million for the second quarter of 2026, driven by strong performance in Automotive Climate and Comfort Solutions.
• The company raised its full-year 2026 guidance, now projecting revenues between $1.55 billion and $1.65 billion, with Adjusted EBITDA expected to be between $185 million and $200 million.
• The strategic combination with Modine Performance Technologies is progressing on schedule, with an expected closing in early Q4 2026, aiming to create a combined entity with over $3.5 billion in pro forma revenue.
• Second quarter Adjusted EBITDA was $48.8 million, with an Adjusted EBITDA margin of 11.7%.
• Free Cash Flow for the second quarter was $16 million, an improvement from -$5 million in the prior year.
• The company secured $690 million in automotive new business awards in the second quarter, bringing the year-to-date total to over $1 billion.
• ThermAffyx received FDA clearance and is currently launching, and the acquisition of Innovative Medical Equipment (IME) expands Gentherm's thermal management portfolio.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive filing, with strong Q2 results, raised guidance, successful product launches, strategic acquisitions, and clear progress on the significant merger with Modine Performance Technologies.

Positives

• Revenue growth of 9.5% (ex-FX) year-over-year in Q2 2026, reaching $416 million.
• Automotive Product delivered record quarterly revenue.
• Strong Automotive Climate and Comfort Solutions growth of 12.7% (ex-FX) year-over-year.
• Raised full-year 2026 revenue guidance to $1.55B - $1.65B.
• Raised full-year 2026 Adjusted EBITDA guidance to $185M - $200M.
• Improved operational execution with a new operating system yielding positive results.
• Secured $690 million in automotive new business awards in Q2, exceeding $1 billion year-to-date.
• ThermAffyx FDA clearance received and launch underway.
• Acquisition of Innovative Medical Equipment (IME) expands thermal management portfolio.
• Merger with Modine Performance Technologies is on track for early Q4 2026 close.
• Second quarter Adjusted Free Cash Flow was $16 million, a significant improvement from -$5 million in the prior year.
• Liquidity increased to $502 million, with net leverage at approximately 0.3x.

Negatives

• Gross Margin percentage decreased slightly to 23.2% in Q2 2026 from 23.9% in Q2 2025.
• Operating Expenses increased to $85.7 million in Q2 2026 from $65.8 million in Q2 2025.
• Margins were pressured by anticipated inflationary and inventory headwinds, as well as higher warranty accruals.
• Capital expenditures were $14.2 million in Q2 YTD, down from $23.7 million in Q2 YTD prior year, indicating potential reduced investment in growth assets.

Risks

• Forward-looking statements are subject to significant assumptions, risks, uncertainties, and other factors that could cause actual results to differ materially.
• The business outlook does not include potential impacts from transactions completed after the filing date, except for the Proposed Transaction.
• New risks emerge from time to time in a competitive and rapidly changing environment.
• The proposed transaction with Modine is subject to customary closing conditions, including regulatory approvals and shareholder approval.
• Potential integration challenges and realization of synergies from the Modine transaction.

Future Outlook

Gentherm raised its full-year 2026 guidance, projecting revenues between $1.55 billion and $1.65 billion, and Adjusted EBITDA between $185 million and $200 million. The company anticipates mid-to-high single-digit growth over the market for 2026 and margin expansion of approximately 30 basis points year-over-year.

Management Comments

• Raising 2026 guidance driven by strong first half results.
• Executing well with strong commercial and operational performance.
• Effectively managing impacts from macro and geopolitical events.
• OEM production schedules continue to remain stable.
• Accelerating strategic profitable growth strategy.
• Selected by home and office customer for fourth consecutive quarter.
• ThermAffyx FDA clearance received; Launch underway.
• Acquired Innovative Medical Equipment (IME); expands thermal management portfolio and sales channels.
• Modine Performance Technologies merger on track for early Q4 close.
• Executing with discipline to deliver strong full year results.

Industry Context

StockSavvy.ai notes that Gentherm's performance in Q2 2026, particularly its revenue growth and raised guidance, appears strong amidst a declining industry light vehicle production forecast. The strategic combination with Modine Performance Technologies positions the combined entity to capitalize on broader thermal and precision flow management markets beyond light vehicles, aligning with industry trends towards diversification and expansion into commercial vehicle and power generation sectors.

Comparison to Industry Standards

• Gentherm's Q2 2026 revenue growth of 9.5% (ex-FX) outpaced the projected industry light vehicle production decline of approximately 3% for the full year 2026.
• The company's Adjusted EBITDA margin of 11.7% in Q2 2026 is a key performance indicator within the automotive supplier sector, where margins can vary significantly based on product mix and operational efficiency.
• The projected pro forma revenue of $3.5 billion+ for the combined Gentherm and Modine Performance Technologies entity would place it as a significant player in the thermal management and precision flow solutions market, comparable to other large Tier 1 automotive suppliers and industrial component manufacturers.

Stakeholder Impact

• Shareholders: Potential for value creation through improved earnings, return of capital, and strategic M&A, as indicated by the raised guidance and new stock repurchase authorization.
• Employees: Potential for expanded opportunities within a larger, combined entity, though integration may also bring changes.
• Customers: Continued supply of automotive climate and comfort solutions, with potential for expanded product offerings through the IME acquisition and the Modine merger.
• Suppliers: Continued business with Gentherm, with potential for increased volume depending on the success of new product launches and market expansion.

Next Steps

• Complete the merger with Modine Performance Technologies in early Q4 2026.
• Launch ThermAffyx product.
• Integrate Innovative Medical Equipment (IME) into Gentherm's portfolio.
• Deliver on initial value creation opportunities from the Modine transaction.
• Continue executing the strategic profitable growth strategy.

Key Dates

Recommendation

While the results are strong and the merger is progressing well, the filing focuses on operational updates and the merger process rather than new financial performance metrics that would warrant a strong buy. The 'hold' recommendation reflects the current execution and strategic positioning, with potential upside contingent on successful merger integration and synergy realization.

Keywords

Gentherm, Modine Manufacturing Company, Performance Technologies, Merger, Business Combination, Automotive Climate Control, Thermal Management, Q2 Earnings